Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

41.98
Delayed Data
As of Mar 24
 +0.48 / +1.16%
Today’s Change
33.56
Today|||52-Week Range
55.15
+8.48%
Year-to-Date

Today’s Trading

Previous close41.50
Today’s open41.65
Day’s range41.38 - 42.26
Volume462,606
Average volume (3 months)1,014,593
Market cap$3.7B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-40.03%
Earnings growth (next 5 years)-32.75%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book11.58

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+1.15+1.32%
NKTRNektar Therapeutics-0.11-0.49%
TECHBio-Techne Corp+0.32+0.31%
KITEKite Pharma Inc+2.34+3.14%
Data as of 4:14pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
President, Chief Operating &
Financial Officer
David-Alexandre C. Gros
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs